Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for depressive symptoms in Parkinson's disease
NCT01055379Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Mar 2010
- Primary completion
- Jul 2012
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by Lundbeck. Started Mar 2010; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01055379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055379.